Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (38)

2024

  1. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

    Neurologia

  2. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Frontiers in Neurology , Vol. 15

  3. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review

    European Journal of Neurology, Vol. 31, Núm. 6

  4. Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

    Journal of Headache and Pain, Vol. 25, Núm. 1

  5. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

    Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937

  6. Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S

    European Journal of Neurology

2023

  1. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, pp. S37-S52

  2. Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, Núm. 9, pp. 635-646

  3. The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside

    Nature Reviews Neurology, Vol. 19, Núm. 8, pp. 489-505

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure

    The journal of headache and pain, Vol. 23, Núm. 1, pp. 133

2021

  1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

    Revista de Neurologia

  2. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

    Journal of Headache and Pain, Vol. 22, Núm. 1

  3. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

  4. Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas

    Scientific Reports, Vol. 11, Núm. 1

  5. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

    Journal of Headache and Pain, Vol. 22, Núm. 1

  6. Neuromodulation in headache and craniofacial neuralgia: guidelines from the Spanish Society of Neurology and the Spanish Society of Neurosurgery

    Neurologia, Vol. 36, Núm. 1, pp. 61-79

  7. Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications

    Neurologia, Vol. 36, Núm. 8, pp. 611-617

2020

  1. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

    Journal of Neuro-Oncology, Vol. 148, Núm. 3, pp. 545-554

  2. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119